Patent · US Active

2′-substituted-N6-substituted purine nucleotides for RNA virus treatment

US10946033B2 · kind B2 · utility

3Cited by
170References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 5, 2019
Grant dateMar 16, 2021
Priority date—
Expiry dateMar 5, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The use of described compounds or pharmaceutically acceptable salts or compositions thereof for the treatment of a host infected with an RNA virus other than HCV, or other disorder more fully described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.